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a  b  s  t  r  a  c  t
Primary  pulmonary  vein  stenosis  (PVS)  is  rare within  the  pediatric  population  and  its pathophysiology
remains  unclear,  especially  as to  how  the histopathology  relates  to  its  refractoriness  to  treatment.  We
report  the  case  of a  4-month-old  girl  with  primary  PVS.  The  lesion  in  this  patient  was characterized  by
fatal  obstruction  of  intraparenchymal  small  pulmonary  veins,  associated  with  localized  stenosis  at  the
four  pulmonary  veno-atrial  junctions.  All four localized  stenoses  underwent  transcatheter  stent  implan-
tation.  Although  the procedure  was  technically  successful,  her clinical  status  failed  to  improve,  and  she
died 2 months  after  stenting.  Histopathological  examination  of  lung  specimens  showed  severe  luminal
obstruction  by  marked  intimal  proliferation  with  ﬁbrosis  in the  intraparenchymal  small  pulmonary  veins,
and these  ﬁndings  were  present  in  every  lobe.  To  the  best  of  our knowledge,  the  histopathological  ﬁnd-
ings  and  clinical  course  in  this  case,  including  the  response  to treatments,  are extremely  rare.  We  suggest
that  the  histological  ﬁndings  of  the  small  pulmonary  veins  are  important  in deciding  the  indication  and
appropriate  timing  of  intervention.
<Learning  objective:  The  outcome  of  primary  pulmonary  vein  stenosis  has  remained  poor  despite
aggressive  treatment,  while  the  indication  and  appropriate  timing  of intervention  has  not  been  clariﬁed.
The histological  ﬁndings  of small  pulmonary  veins  are  important  to  predict  the  response  to  treatment
and  outcome,  and  early  intervention  might  prevent  the secondary  progression  of  this  disease.>
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Pulmonary vein stenosis (PVS) is usually associated with other
ongenital heart diseases, such as total anomalous pulmonary
enous connection and heterotaxy syndrome, and primary PVS, i.e.
solated cardiac lesion with normal pulmonary vein connection, is
are within the pediatric population [1–5]. The Pediatric Cardiac
are Consortium (PCCC; Minneapolis, MN,  USA) database reported
n incidence of primary PVS of 0.03% (31 of 98,126) in a popu-
ation of patients with congenital heart disease who underwent
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catheterization or surgery [3]. Although, the pathologic process
of this disease is recognized as myoﬁbroblast proliferation rather
than inadequate embryological connection between the intrapul-
monary venous system [6–8], the precise pathogenesis has not yet
been identiﬁed. Surgical repair and stent implantation are applied
in managing primary PVS [9–11]. However, the outcome of this dis-
ease has remained poor despite aggressive treatment [2,3,6], while
the indication and appropriate timing of intervention has not been
clariﬁed.
Case reportA 3-month-old girl, born at full term and body weight of 2852 g
following an uncomplicated pregnancy was noted to be failing to
thrive. She had no speciﬁc family history. She was  admitted to
vier Ltd. All rights reserved.
4 Cardio
o
r
r
b
5
2
b
4
e
d
a
u
a
h
v
o
o
ﬂ
I T. Fujii et al. / Journal of 
ur department at the age of 4 months because of cyanosis and
espiratory distress.
On admission her body weight was 5.1 kg. She had dyspnea with
etractions and deep cyanosis. Her SpO2 was 74%, heart rate 160
eats/min, systolic blood pressure 90 mmHg, and respiratory rate
0 min–1. The second heart sound was accentuated, while a grade
/6 pansystolic murmur was audible over the lower left sternal
order. Her jugular vein was distended and the liver was  palpable
 cm below the right costal margin.
Laboratory data were non-speciﬁc for complete blood count,
lectrolytes, renal, and hepatic proﬁles. A chest X-ray showed a car-
iothoracic ratio of 57% with marked pulmonary venous congestion
nd pulmonary emphysema (Fig. 1a). Her electrocardiogram doc-
mented right ventricular hypertrophy, right atrial enlargement,
nd sinus rhythm. Echocardiogram showed severe pulmonary
ypertension with a dilated right ventricle, moderate tricuspid
alve regurgitation and right-to-left shunting across the foramen
vale. Pulmonary veins were not considered to be obstructed
n echocardiography, because speciﬁc ﬁndings like non-phasic
ow or ﬂow velocity acceleration were not recognized (Fig. 2).
nhaled nitric oxide and intravenous epoprostenol were started
Fig. 1. Chest X-ray on admission (a), after inhaled n
Fig. 2. Echocardiogram on admission, short-axis view (a), four-chamber viewlogy Cases 9 (2014) 3–7
immediately after admission. The pulmonary arterial pressure and
oxygen saturation improved shortly after starting treatment; how-
ever, this improvement was followed by a dramatic deterioration
of pulmonary venous congestion (Fig. 1b). Subsequently, her clin-
ical condition remained critical associated with severe pulmonary
hypertension, right heart failure, and pulmonary venous conges-
tion. Her condition gradually deteriorated despite various medical
treatments. When she was  11 months, we  performed computed
tomography and cardiac catheterization to evaluate the morphol-
ogy of the pulmonary veins and assess if there was any indication
for intervention.
Cardiac catheterization demonstrated a pulmonary arterial
pressure of 100/60 (mean 75) mmHg; pulmonary to systemic
pressure ratio was 0.76. Pulmonary venous pressure was also
increased to 40 mmHg, while pulmonary capillary wedge pressure
was 23 mmHg. The pulmonary venous pressure data were obtained
by direct insertion of catheter into pulmonary vein, so the high pres-
sure might be inﬂuenced by obstruction of the inserted catheter.
Left ventricular end-diastolic pressure was  20 mmHg  and central
venous pressure was  17 mmHg. We  consider that elevated left
ventricular end-diastolic pressure probably resulted from severe
itric oxide and epoprostenol were started (b).
 (b). LV, left ventricle; RV, right ventricle; TR, tricuspid regurgitation.
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ompression by highly dilated right ventricle. Computed tomo-
raphy and pulmonary venous angiography documented localized
tenosis of all 4 pulmonary veins at the veno-atrial junction
Figs. 3 and 4a), and we decided to perform transcatheter stent
mplantation for these stenoses.
We sequentially implanted Express vascular SD stent (Boston
cientiﬁc, Natick, MA,  USA) in 4 pulmonary veins with techni-
al success (Fig. 4b). As some of these lesions were markedly
rm, an ultra-high-pressure balloon such as Conquest (Bard,
empe, AZ, USA) was required for ﬁnal dilatation in the right
ulmonary veins. The ﬁnal diameter of the balloon was  7 mm
n the right upper and lower pulmonary veins, 6 mm in the
eft lower, and 5 mm at left upper pulmonary vein. Although
ig. 3. Computed tomography of pulmonary venous connection to the left. White arrow 
ulmonary vein; LUPV, left upper pulmonary vein; LLPV, left lower pulmonary vein; LA, l
ig. 4. Pulmonary venogram before (a) and after stent implantation (b). RUPV, right uppe
ein;  LLPV, left lower pulmonary vein; 4Fr JR, 4 French Right Judkins catheter.logy Cases 9 (2014) 3–7 5
the lumen of the pulmonary vein at the stenotic veno-atrial
junction was  secured sufﬁciently, her hemodynamic condition
remained critical; the pulmonary to systemic pressure ratio only
decreased from 0.76 to 0.70, and she died 2 months after the stent
implantation.
Autopsy was  performed, and lung specimens were obtained
from bilateral lungs. Histopathological examination showed severe
luminal obstruction by marked intimal proliferation with ﬁbrosis
in the intraparenchymal small pulmonary veins, and these ﬁndings
were present in every lobe (Fig. 5). There was no luminal obstruc-
tion without irreversible intimal ﬁbrosis, in small pulmonary
arteries, while internal elastic membrane was well extended which
suggested effectiveness of the pulmonary vasodilator.
shows the narrowest points. RUPV, right upper pulmonary vein; RLPV, right lower
eft atrium. atrium.
r pulmonary vein; RLPV, right lower pulmonary vein; LUPV, left upper pulmonary
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iscussion
We  report the case of an infant complicated by primary PVS,
hich is an extremely rare disease characterized by fatal obstruc-
ion of intraparenchymal small pulmonary veins, associated with
ocalized stenosis of all 4 pulmonary veno-atrial junctions. Conse-
uently, she developed severe pulmonary hypertension, right heart
ailure, and pulmonary venous congestion. Stenoses at the veno-
trial junction were effectively dilated by stent implantation, and
mall pulmonary artery lumen was well patent which suggested
ffectiveness of the pulmonary vasodilator. However, she failed to
ecover from the critical pulmonary hypertension. Therefore, we
elieve that the coexistence of fatal obstruction of small pulmonary
eins is the main cause that contributed to ineffectiveness of vari-
us treatments in this patient. Previous reports have described that
ntimal proliferation in small pulmonary veins was shown in asso-
iation with primary PVS [1,2,6–8,12]. However, it is difﬁcult to
redict acute response to treatment and subsequent outcome by
he histopathological ﬁndings of small pulmonary vein [2,12,13].
The intimal proliferation demonstrated in this patient probably
onsists of “myoﬁbroblast” judging from microscopic characteris-
ics, such as abnormal spindle form [7,8]. Some cases were reported,
ho had intimal proliferation of stenotic small pulmonary veins not
nly in the lung with pulmonary venous obstruction but also in the
ung without obstruction [8]. Meanwhile, other authors hypothe-
ized that PVS began as a discrete localized stenosis, which then
rogressed to involve longer segments of the intraparenchymal
ulmonary veins, on the base of serial imaging studies [7]. The
uthors of a second report also speculated that as a discrete steno-
is at the pulmonary veno-atrial junction would have progressed
o diffuse obstruction of small pulmonary veins and ﬁnally to com-
lete occlusion, early intervention should be important [2]. These
eports suggested that obstruction in the small pulmonary vein
n primary PVS might be a secondary change to increased venous
ressure, caused by localized stenosis downstream. Consequently,
e suppose that early stent implantation, before development of
econdary small vein obstruction might have prevented the pro-
ression of the disease in this patient.
A patient diagnosed at 18 months of age, having initial mean
ulmonary arterial pressures >33 mmHg  or with bilateral vessel
nvolvement was  at signiﬁcant high risk of lung death or trans-
lantation, with the risk up to around 80% [3]. It is known that
ortality and recurrence rate for the primary PVS are higher than
or secondary PVS such as that following repair of total anoma-
ous pulmonary venous connection [3,9]. We  believe that our
atient inherently had extremely poor prognostic features despite small pulmonary vein (a), (b).
any intervention. There may  be more patients than previously
understood who  have the histological features of fatal obstruction
of small pulmonary veins, similar to our patient, particularly in
patients who do not respond to treatment. Therefore, histologi-
cal ﬁndings of small pulmonary veins will be extremely important
to decide the indication and appropriate timing of intervention.
Although the cause of small pulmonary vein obstruction is proba-
bly multifactorial, it might be a secondary progression caused by
localized stenosis in some cases. When small PVS already exists,
response to intervention is more likely to be poor, so early inter-
vention may  be necessary as soon as possible to prevent secondary
progression of small pulmonary vein obstruction, if primary PVS
was recognized.
Conclusion
We  reported an infant with primary PVS, characterized by fatal
obstruction of intraparenchymal small pulmonary vein, associated
with localized stenosis of all 4 pulmonary veno-atrial junctions.
Stent implantation for these stenoses was not effective in this
patient, mainly because of the small pulmonary veins obstruction.
The histological ﬁndings of small pulmonary veins are extremely
important to predict the response to treatment and outcome, and
early intervention might prevent the secondary progression of this
disease.
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